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Sonic Hedgehog (Shh) and its patched-smoothened receptor complex control a variety of functions in 
the early developing central nervous system (CNS) such as neural cell proliferation and differentiation. 
Recently, Shh signaling components have been found to be expressed at the synaptic level in the 
postnatal and adult brain, suggesting a potential role in the regulation of synaptic transmission. Here, 
using in utero electroporation of constitutively active and dominant-negative forms of the Shh co-
receptor smoothened (Smo), we studied the role of Shh-Smo signaling in the development and 
maturation of GABAergic transmission in rat somatosensory cortex. Our results show that enhancing 
Smo activity during development accelerates the shift from depolarizing to hyperpolarizing GABA in 
dependence on functional expression of potassium-chloride cotransporter type 2 (KCC2). On the other 
hand, blocking Smo activity maintains GABA response in a depolarizing state in mature cortical neurons 
resulting in altered chloride homeostasis and increased seizure susceptibility. Altogether, our study 
reveals an unexpected function of Shh signaling on the regulation of chloride homeostasis through the 
control of KCC2 cell surface stability and, in particular, on the timing of the GABA inhibitory/excitatory 
shift in brain maturation.  





Sonic hedgehog (Shh) is an activity-dependent secreted synaptic molecule (Beug et al., 2011). In the 
presence of Shh ligand, receptor Patched-1 (Ptch1) relieves its constitutive inhibition on G-protein 
coupled co-receptor Smoothened (Smo), leading to activation of downstream signaling factors (Riobo 
et al., 2006; Briscoe and Thérond, 2013; Belgacem and Borodinsky, 2015). Shh signaling plays a wide 
range of functions during embryonic development from neuronal cell proliferation to differentiation 
(Traiffort et al., 2010; Ruat et al., 2012; Briscoe and Thérond, 2013; Belgacem et al., 2016). 
Furthermore, in the developing mammalian central nervous system, Shh signaling is involved in axonal 
elongation (Hammond et al., 2009; Parra and Zou, 2010; Yao et al., 2015) and formation of the cortical 
connectivity (Harwell et al., 2012; Memi et al., 2018). After birth, Shh signaling components have been 
found in several brain regions, including the cerebral cortex and hippocampus, from an early stage of 
postnatal development to adulthood (Charytoniuk et al., 2002; Traiffort et al., 2010; Petralia et al., 2011, 
2012; Rivell et al., 2019). In the adult hippocampus, Shh plays an essential role in neurogenesis in the 
dentate gyrus (Breunig et al., 2008; Antonelli et al., 2019). In addition, Shh receptors Ptch1 and Smo 
are also expressed at the synaptic junction of the immature and adult hippocampus (Charytoniuk et al., 
2002; Petralia et al., 2011; Mitchell et al., 2012), suggesting other roles than control of neurogenesis 
(Zuñiga and Stoeckli, 2017). For instance, Shh was reported to exert a modulatory action on neuronal 
electrical activity in the adult brain (Bezard et al., 2003; Pascual et al., 2005) and more recently Shh 
signaling has been shown to regulates the formation of glutamatergic and GABAergic terminals in 
hippocampal neurons (Mitchell et al., 2012). These morphological changes were accompanied by an 
increase in the frequency of excitatory postsynaptic currents (Mitchell et al., 2012; Feng et al., 2016). 
Altogether, these findings support the view that the Shh signaling pathway plays a crucial role during 
early postnatal neuronal circuit construction and synaptic plasticity in the hippocampus and cortex. 
Thus, its impairment may affect neuronal network formation and lead to brain dysfunction. Likewise, 
both in human and animal models accumulating evidences indicate that impairment of Shh pathway at 
postnatal stages may contribute for the emergence of neurodevelopmental disorders, including autism 
spectrum disorders (ASD) (Al-Ayadhi, 2012; Halepoto et al., 2015) and seizures (Feng et al., 2016; Su 
et al., 2017).  




In the early postnatal life, the GABAA receptor function changes from depolarizing to 
hyperpolarizing in a KCC2 dependent manner (Ben-Ari et al., 1989; Rivera et al., 1999). Alteration in 
the GABA developmental sequence leads to compromised balance between excitatory and inhibitory 
transmission associated with severe changes in the neuronal network circuitry (Ben-Ari, 2002; Ben-Ari 
et al., 2007; Wang and Kriegstein, 2009; Sernagor et al., 2010; Kilb et al., 2013) and subsequently, the 
onset of neurodevelopmental brain disorders (Ben-Ari and Holmes, 2005; Kuzirian and Paradis, 2011; 
Mueller et al., 2015). 
Although both Shh and GABA signaling are critically involved in similar processes of neuronal 
network formation and are implicated in etiology of same neurodevelopmental disorders, their putative 
interplay remains unclear. Here we postulated that Shh components may contribute to the onset of the 
GABA polarity shift and suggested that deregulation of Shh signaling pathway may then lead to an 
impaired neuronal network and to the emergence of brain disorders at adulthood. Because loss of 
function of Smo have an embryonic lethal phenotype (Zhang et al., 2001) and Smo activation in Wnt1-
Cre;R26SmoM2 mice induces a hyperplasia of the facial processes at embryonic stages (Jeong et al., 
2004), we used in utero electroporation (IUE) to target the somatosensory cortex with constructs 
encoding either for the dominant-negative (Smo Δ570-581, called Smo-DN) (Kim et al., 2009) or the 
constitutively active (Smo A1, called Smo-CA) (Chen et al., 2011) Smo variants. Our results reveal an 
unexpected function for Shh/Ptch/Smo signaling pathway in the regulation of GABAergic 
developmental timing in the rat cerebral cortex, notably through the modulation of cell surface 
expression and stability of KCC2. We further show that impairment of Shh signaling alters the 
phosphorylated state of KCC2, thus maintaining a depolarizing action of GABA, which leads to an 
alteration of GABAergic inhibitory transmission and may contribute to the emergence of brain 
disorders. 




Material and methods 
All animal procedures were carried out according to the guidelines
 
set by the INSERM animal welfare 
through the local committee (CEEA n°14) and the European Communities Council Directives 
(2010/63/UE). Male and female Wistar rats were purchased from Janvier Labs (https://www.janvier-
labs.com/fiche_produit/rat_wistar/). Animals were raised and mated at INMED A2 animal facility 
housed under a 12 h light/dark cycle at 22-24°C and had access to food and water ad libitum.  
 
Reagents and treatments 
The following reagents were purchased from the indicated sources: 1,2,3,4-Tetrahydro-6-nitro-2,3-
dioxo-benzo[f]quinoxaline-7-sulfonamide (NBQX) was obtained from the Molecular, Cellular and 
Genomic Neuroscience Research Branch (MCGNRB) of the National Institute of Mental Health 
(NIMH, Bethesda, MD, USA). TTX was purchased from abcam (Cambridge,
 
UK). Isoguvacine, 
bicuculline and VU0463271 were purchased from Tocris Cookson (Bristol, UK). Strychnine and 
Bumetanide from Sigma (St-Louis, Missouri, USA). 
 
In utero electroporation  
In utero injections and electroporations were performed in embryos from timed pregnant rats 
(embryonic day 15) that received buprenorphine (Buprecare at 0.03 mg/kg) and were anaesthetized 
with sevoflurane (4.5%) 30 minutes later (Martineau et al., 2018). Briefly, the uterine horns were 
exposed, and a lateral ventricle of each embryo was injected using pulled glass capillaries and a 
microinjector (PV 820 Pneumatic PicoPump; World Precision Instruments, Sarasota, FL) with Fast 
Green (2 mg/ml; Sigma, St Louis, MO, USA) combined with the following DNA constructs encoding 
GFP or mCherry and/or Smo-DN and/or Smo-CA and/or Cl-Sensor (ratio 1:2). Plasmids were further 
electroporated by delivering 40V voltage pulses with a BTX ECM 830 electroporator (BTX Harvard 
Apparatus, Holliston, MA, USA). The voltage was discharged in five electrical pulses at 950 ms 
intervals via tweezer-type electrodes (Nepa Gene Co, Chiba, Japan) placed on the head of the 
embryo across the uterine wall. We performed in utero electroporation in embryonic rats at E15, 




corresponding to an active period of both radial and tangential migration of newborn neurons in the 
cortex (Kriegstein and Noctor, 2004). At birth, successfully electroporated pups were selected after 
transcranial visualization of the GFP reporter fluorescent proteins only. Following 
experimentation, morphological analysis of electroporated tissues, selected by GFP or mCherry 
expression under fluorescent stereomicroscope (Olympus SZX 16), was performed. The criteria 
commonly used for selection of animals were localization and cell density of transfected cortices and 
absence of abnormal cortex morphology (i.e. cortical disruption, thickening and abnormal cortical 
organization). Our analyses revealed no alterations in cortical layer position or morphology in GFP or 
mCherry, Smo-CA and Smo-DN conditions, although we cannot exclude the possibility that Smo 
constructs impact the neuronal cells at the cellular and subcellular levels. Nevertheless, approximately 
20% of electroporation failed due to the absence of transfected cells as revealed by the lack of 
fluorescent cells (in GFP or mCherry and Smo conditions). These animals were excluded from the study. 
 
Western blotting  
Electroporated zones of the somatosensory cortex were homogenized in RIPA buffer (150 mM NaCl, 
1% Triton X-100, 0,1% SDS, 50 mM Tris HCl, pH 8, containing protease inhibitors (Complete Mini; 
Roche). Lysates were centrifuged (10.000g for 10 min at 4°C) and the supernatant was heated at 90°C 
for 5 min with Laemmli loading buffer. Loading was 20 µg of proteins as determined using a modified 
Bradford reaction (BioRad Laboratories). Proteins were separated in 7–15% SDS-PAGE and 
electrophoretically transferred to nitrocellulose membranes. Membranes were blocked with 5% Bovine 
Serum Albumin (BSA) in TBS 0,1% Tween 20 (TBST) for 2h at RT, then incubated with primary 
antibodies diluted in TBST containing 3% BSA overnight at 4°C or 2h at RT. Blots were probed with 
antibody against KCC2 pSer940 (1 mg/ml; rabbit, Novus Biologicals), KCC2 pThr1007 (1 mg/ml; sheep, 
Division of Signal Transduction Therapy Unit (DSTT), University of Dundee), and KCC2 (1:2000; 
rabbit, US Biological). After washing with TBST, membranes were incubated with HRP-conjugated 
secondary antibodies diluted in TBST containing 3% BSA for 60 min, washed with TBST and then 
developed using the G:BOX gel imaging system (Syngene). The appropriate exposure time of the digital 




camera for acquisition of chemiluminescent signals from immunoblots was adapted to avoid saturated 
pixels and expression levels were estimated by Image J software (NIH, Bethesda, MD; 
http://rsb.info.nih.gov/ij/).  
 
Immunocytochemistry and confocal microscopy 
Under deep anesthesia with isoflurane prior to chloral hydrate (7% in PBS 1M), P10 to P30 
electroporated rats were intracardially perfused with cold PBS (1M) followed by 4% PFA in PBS. Brains 
were removed, post-fixed overnight at 4°C and rinsed in PBS. Coronal cortical sections (70μm thick) 
were obtained using a vibratome (Microm HM 650V). Sections were incubated first for 1 h in PBS with 
1% BSA and 0.3% Triton X-100, then overnight at 4°C with rabbit anti-Smo (1:500; ab38686; Abcam) 
or rabbit anti-caspase-3 cleaved (1:500; 9661S; Cell Signaling) or chicken anti-MAP2 (1:5000; ab5392; 
Abcam) or mouse anti-NeuN (1:1000; MAB377; Chemicon), or rabbit anti-FoxP2 (1:4000; ab16046; 
Abcam), or mouse anti-synaptophysin (1:000; MAB5258; Chemicon). Sections were rinsed in PBS and 
incubated for 2h with the corresponding Alexa488 (1:1000; FluoProbes), Cy5 or Cy3-conjugated 
secondary antibodies diluted in PBS (1:1000; Chemicon). DAPI staining was applied for nuclear 
localization (Vector Laboratories H-1200). Control tissues used to determine the level of nonspecific 
staining included tissues incubated without primary antibody. Sequential acquisition of 
immunoreactivity of GFP positive pyramidal-like cells was performed using laser scanning confocal 
microscope (Zeiss LSM 510 Meta) with a 40X or 63X oil-immersion objectives. For each experimental 
condition, a semi-quantitative analysis of Synaptophysin (Syn) labeled area fraction per field was 
measured and reported to the area fraction of positive pixels for MAP2. The surface areas of NeuN 
immuno-positive neurons expressing GFP or Smo-related constructs were measured manually using the 
Freehands selection tool in Image J. In each set of images, laser light levels and detector gain and offset 
were adjusted to avoid any saturated levels. Optical sections were digitized (1024 × 1024 pixels) and 
processed using Image J software. All of the images were analyzed blindly. 
 
Relative Quantitative Expression of mRNA transcripts  




Expressions of Gli1 and Ptch1 mRNA in the electroporated regions of the somatosensory cortex were 
measured by real-time quantitative RT-PCR. Total RNAs were isolated from cerebral cortices (P15 rats) 
using Mini RNeasy kit (Qiagen) then converted to cDNA using 1 µg RNA and a QuantiTect Reverse 
Transcription kit (Qiagen) according to manufacturer’s instructions. PCR was carried out with the 
LightCycler 480 SYBR Green I Master (Roche Applied Science) with 1 µL cDNA using the following 
oligonucleotides (QuantiTect Primer Assays, Qiagen): Gli1 (Gli1; QT01290324), Ptch1 (QT01579669), 
KCC2 (Slc12a5; QT00145327) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 
QT001199633). Quantitative RT-PCR was performed with a Roche LC480 LightCycler (Roche Applied 
Science) following the manufacturer’s instructions. Relative mRNA values were calculated using the 
LC480 software and GAPDH as the housekeeping gene. PCR was performed in replicates of 3. 
 
Sonic hedgehog protein (Shh) immunoassay  
Cortical tissues from electroporated rats at the indicated age were homogenized in RIPA buffer (150 
mM NaCl, 1% Triton X-100, 0.1% SDS, 50 mM Tris HCl, pH 8, containing protease inhibitors 
(Complete Mini; Roche)). Lysates were centrifuged (5000 g for 5 min at 4°C). Loading was 200 µg of 
protein as determined using a modified Bradford reaction (BioRad Laboratories). Quantification of Shh 
was performed with Rat Shh ELISA Kit (FineTest, Wuhan Fine Biotech Co. Ltd., China) in the 
concentrated solutions following the manufacturer’s protocol. Experiments and analysis were done 
blindly. 
 
Slices preparation and electrophysiological recordings  
Electroporated cortical regions of the P14 rat were identified using an atlas of the developing rat brain  
(Khazipov et al., 2015). Electroporated cortical regions of the P20 and P30 rat were identified using the 
Paxinos and Watson rat brain atlas (Paxinos and Watson, 2005). Based on these two atlases, the 
somatosensory regions were prepared for acute slice experiments from P14, P20 and P30 rats in ice-
cold (2-4°C) oxygenated modified artificial cerebrospinal fluid (ACSF) (0.5mM CaCl2 and 7mM 
MgSO4; NaCl replaced by an equimolar concentration of choline). Slices (300 µm thick) were cut with 
a Vibratome (VT1000E; Leica, Nussloch, Germany) and kept at room temperature (25°C) for at least 




one hour before recording in oxygenated normal ACSF containing (in mM): 126 NaCl, 3.5 KCl, 2 CaCl2, 
1.3 MgCl2, 1.2 NaH2PO4, 25 NaHCO3 and 11 glucose, pH 7.4 equilibrated with 95% O2 and 5% CO2. 
Slices were then transferred to a submerged recording chamber perfused with ACSF (3 mL/min) at 
34°C. 
 
Spiking activity and data analysis  
Extracellular field potential recordings were performed from P14, P20 and P30 electroporated 
somatosensory cortical slices. Extracellular tungsten electrodes of 50µm diameter (California Fine Wire, 
Grover Beach, CA, USA) were positioned in the V/VI cortical pyramidal cell layer of the transfected 
area to record the Multi Unit Activity (MUA). Field potentials were recorded using a DAM80 Amplifier 
(World Precision Instruments, Sarasota, FL, USA) using a 1–3 Hz bandpass filter and analyzed off-line 
with the Axon package MiniAnalysis program (Jaejin Software, Leonia, NJ, USA). To determine the 
developmental changes in the GABAA signaling, we used isoguvacine, a potent and selective GABAA 
receptor agonist (Krogsgaard-Larsen and Johnston, 1978). We determined the effect of isoguvacine on 
MUA as a ratio of the spiking frequency at the peak of the isoguvacine response to the spiking frequency 
in control.  
 
Cl--Sensor fluorescence recordings from brain slices  
To perform a non-invasive monitoring of neuronal intracellular chloride concentration ([Cl-]i) we used 
a ratiometric genetically-encoded Cl--sensitive probe called Cl-Sensor (Markova et al., 2008; Waseem 
et al., 2010) that was co-expressed into the cells of interest together with other constructs as described 
above. The acquisition of fluorescence images was performed using a customized imaging set-up and 
consecutive cells excitation at 430 and 500 nm and emission at 480 and 540 nm.  The frequency of 
acquisition was 0.05 Hz. The duration of excitation was selected for each cell type and was selected to 
avoid use-dependent bleaching of the signal (Friedel et al., 2013). Results are expressed as ratio 
R430/500. Experiments were performed on acute cortical slices from in utero electroporated rat pups 
on postnatal days P10 and P30. Individual slices were transferred to a specially designed recording 
chamber where they were fully submerged and superfused with oxygenated ACSF complemented with 




1 µM tetrodotoxin, 0.3 µM strychnine, and 10 µM NBQX to prevent spontaneous neuronal activity and 
noncontrolled [Cl− ]i changes at 30–32°C at a rate of 2–3 ml/min. The applications of the ACSF solution 
containing isoguvacine (30 µM) or KCl (25 mM) + isoguvacine (30 µM) were performed with a 
perfusion system.  
 
Seizure induction with pentylenetetrazol (PTZ)   
To evaluate the susceptibility to seizures in controls rats (GFP-transfected brains), in Smo-CA and Smo-
DN animals at P30, PTZ (25 mg/kg; Sigma) was administered via intraperitoneal injections every 10 
min until generalized seizures occurred. Rats were placed in a plexiglass cage and the time to the onset 
of the generalized seizure was measured by observation. There was no significant difference in weight 
and sex between groups of animals. Experiments were done blind and the electroporated region was 
verified after PTZ induction. Rats with a very focal fluorescence or fluorescence in other brain regions 
than somatosensory cortex were excluded. 
 
Primary cultures and transfection of rat hippocampal neurons  
Neurons from 18-day-old rat embryos were dissected and dissociated using trypsin and plated at a 
density of 70,000 cells cm−2 in minimal essential medium (MEM) supplemented with 10% NU serum 
(BD Biosciences, Le Pont de Claix, France), 0.45% glucose, 1 mM sodium pyruvate, 2 mM glutamine 
and 10 U ml−1 penicillin–streptomycin (Buerli et al., 2007). On days 7, 10 and 13 of culture incubation 
(DIV, days in vitro), half of the medium was changed to MEM with 2% B27 supplement (Invitrogen). 
For electrophysiology, neuronal cultures were plated on coverslips placed in 35-mm culture dishes. 
Twelve hours before plating, dishes with coverslips were coated with polyethylenimine (5 mg/ml). 
Transfection of cultured neurons was performed with 300 µl Opti-MEM medium mixed with 7 µl 
Lipofectamine 2000 (Invitrogen), 1 µl Magnetofection CombiMag (OZ Biosciences) per µg of DNA 
and 1.5 µg premixed DNAs encoding constructs of interest. The mixture was incubated for 20 min at 
room temperature and thereafter distributed dropwise above the neuronal culture. Culture dishes (35-
mm) were placed on a magnetic plate (OZ Biosciences) and incubated for 35 min at 37°C, 5% CO2. 




Transfection was terminated by the substitution of 80% of the incubation solution with fresh culture 
medium. Cells were used in the experiments 48-72 hours after transfection. These experiments were 
based on co-transfection into the same cell of two different pcDNAs encoding a fluorescent marker of 
transfection (eGFP or mCherry, 0.3 µg), and Smo-related constructs (1.2 µg).  
 
Gramicidin-perforated patch-clamp recordings  
Gramicidin-perforated patch-clamp recordings were performed on primary hippocampal neurons, 
transfected with a mixture of constructs encoding mCherry (mock) or Smo-DN or Smo-CA with or 
without KCC2-pHext (Friedel et al., 2017). Measurements were performed 2 or 3 days after transfection 
(corresponding to 8 or 9 DIV). Coverslips with transfected neurons were placed onto the inverted 
microscope and perfused with an external Hepes-buffered solution (HBS) (in mM): 140 NaCl, 2.5 KCl, 
20 Hepes, 20 d-glucose, 2.0 CaCl2, 2.0 MgCl2, and 0.02 Bumetanide, pH 7.4. For recording from 
neurons, external HBS contained 0.5 µM tetrodotoxin and 15 µM bumetanide. The recording 
micropipettes (5 MΩ) were filled with a solution containing (in mM): 150 KCl, 10 Hepes, and 20 µg/ml 
gramicidin A, pH 7.2. Isoguvacine (30 µM) was dissolved in an external solution and focally applied to 
recorded cells through a micropipette connected to a Picospritzer (General Valve Corporation, pressure 
5 p.s.i.). Recordings were done using an Axopatch-200A amplifier and pCLAMP acquisition software 
(Molecular Devices) in voltage-clamp mode. Data were low-pass filtered at 2 kHz and acquired at 10 
kHz. Isoguvacine responses were recorded at voltages -110, -90, -70 and -50 mV or at -70, -50, -30 and 
-10 mV depending on neuron GABA inversion potential. A linear regression was used to calculate the 
best-fit line of the voltage dependence of the isoguvacine responses.  
 
Surface immunolabeling on living neurons and analysis of KCC2-pHext proteins 
For immunolabeling of KCC2-pHext proteins on living neurons, rabbit anti-GFP antibody were dissolved 
in culture media applied to neurons for 2 hours at 37°C, 5% CO2 (Friedel et al., 2015). Neurons were 
then rinsed three times at room temperature (RT) with HBS, labeled with anti-rabbit Cy3-conjugated 
antibody for 20 min at 13°C and fixed in Antigenfix (Diapath). To reveal intracellular pool of live-
labelled proteins, cells were permeabilized with 0.3% Triton X-100, blocked by 5% goat serum and 




incubated during 1 h at RT with anti-rabbit Alexa 647-conjugated antibody. For visualization of the total 
pool of overexpressed KCC2-pHext cells were labeled overnight (4°C) with mouse anti-GFP antibody 
and for 1 hour at RT with anti-mouse Alexa 488-conjugated antibody. For control of the cell membrane 
integrity during live-cell immunolabeling, one batch of cultures were routinely transfected with KCC2-
pHext mutant ΔNTD-KCC2-pHext that does not incorporate into the plasma membrane (Friedel et al., 
2017). KCC2 A/A, a double phosphomimetic mutant of KCC2 for T906A/T1007A that maintains KCC2 
at the cell surface (Friedel et al., 2015) was used as a positive control. 
Images of labeled neurons were acquired with an Olympus Fluorview-500 confocal microscope 
(oil-immersion objective 60x (NA1.4); zoom 1-5). We randomly selected and focused on a transfected 
cell by only visualizing Alexa-488 fluorescence and then acquired Z-stack images of Alexa-488, CY3 
and Alexa-647 fluorochromes. Each Z-stack included 10 planes of 1 µm optical thickness and taken at 
0.5 µm distance between planes. The cluster properties and fluorescence intensities of each cell were 
analyzed with Metamorph software. First, we used the logical “NOT” conversion of pairs of Alexa-647 
and CY3 images to isolate in each focal plane the Alexa-647 signal that was not overlapping with CY3 
fluorescence restricted to plasma membrane. This gave rise to additional images reflecting the 
fluorescence of the internalized pool of labeled clusters, called thereafter “NOT-conversion”. Second, 
the arithmetic summation for each Z-stack and channel was performed to collect the whole fluorescence 
of the different signals (Alexa-488 = total protein fluorescence; CY3 = plasma membrane restricted 
fluorescence; NOT-conversion = internalized restricted fluorescence; Alexa-647 = all surface labeled 
fluorescence). Third, a binary mask was created for each cell from Alexa-488 image to isolate the signal 
coming from the transfected neuron, and the fluorescence parameters (total fluorescence, single cluster 
fluorescence as well as density and brightness of clusters) were analyzed for each channel (Alexa-488, 
CY3, NOT-conversion and Alexa-647) in regions overlapping with the binary mask. The analysis 
parameters were the same for each experiment and all experiments were done blind. After analysis, data 
were normalized to the mean value of cells transfected with KCC2-pHext + GFP. 
 
Statistical analysis 
No statistical methods were used to predetermine sample sizes. To ensure the consistency and 




reproducibility of our results, we conducted repeated trials in different cell cultures and acute brain slices 
prepared from at least three different animals for each experimental condition. If not stated otherwise, 
statistics are presented as the mean ± the standard deviation (SD) for normaly distributed data and as 
the median only for non-normaly distributed data. Experiments with control and Smo electroporated 
animals were processed at the same time to ensure homogeneity of experimental conditions. Statistical 
analyses and assessment of normal distribution (Shapiro-Wilk test) were performed with GraphPad 
Prism (GraphPad software 5.01). For data showing normal distribution, ANOVA and the post hoc Tukey 
test were used for multiple comparisons between groups, and a paired t-test was used to compare paired 
data. For data displaying non-normal distribution Kruskal-Wallis test was used to compare three of more 
independent groups, Mann-Whitney U-test was used for comparison between 2 independent groups and 
Wilcoxon matched-pairs signed rank test to analyze differences within one group across conditions. 















Cortical expression pattern of Smo-CA and Smo-DN 
Previous studies have shown that Shh signaling pathways components, including Ptch1 and Smo, are 




present in the postnatal mammalian brain (Petralia et al., 2011; Harwell et al., 2012; Mitchell et al., 
2012; Rivell et al., 2019). In the mouse neocortex, Shh signaling regulates the formation of neuronal 
network in immature brain, suggesting a potential function in construction and maturation of neural 
circuits during the postnatal periods. In order to evaluate its role in the developing brain, we used IUE 
of plasmids to express GFP alone as control or in combination with constitutively active (Smo-CA) or 
dominant-negative (Smo-DN) forms of Smo, an essential component for Shh signaling. IUE of rat brains 
was performed at embryonic day 15 (E15) in order to target mainly pyramidal neurons of the layers 
V/VI (Kriegstein and Noctor, 2004). Coronal sections through the somatosensory cortex of GFP and 
Smo-related constructs co-electroporated tissues from P15 rodents were immunolabeled with neuronal 
markers NeuN and FoxP2 (deeper layer neurons markers) to assist in the histological identification of 
cortical layers (Fig. 1A). The fluorescence intensity profile of both Smo-CA and Smo-DN expressing 
neurons does not show any obvious differences in the cortical layering when compared to control GFP-
expressing cells. Thus, Smo-CA or Smo-DN expressing neurons electroporated at E15 most likely 
represent the layers V/VI of the somatosensory cortex.  
Because Shh signaling is involved in cell division and cell growth of cerebral cortex progenitors 
(Araújo et al., 2014), we investigated whether Smo-related constructs could impact the cortical thickness 
or the neuronal cell density and size in electroporated tissues. We found that cortical thickness of Smo-
CA and Smo-DN rats does not present any difference compared to control rats (median values: 1772 
µm, 1779 µm and 1772 µm respectively; p = 0.07 between Smo-CA and control rats, p = 0.17 between 
Smo-DN and control, Mann-Whitney test; Fig. 1B). The density of NeuN immuno-positive cells in Smo-
CA and Smo-DN electroporated somatosensory cortices, measured in the layer V, reveals no difference 
when compared to control tissues (46 neurons per observation field for control, vs 41 neurons for Smo-
CA; p = 0.72 and 41 neurons for Smo-DN; p = 0.44, Mann-Whitney test; Fig. 1C). Similarly, the average 
soma neuronal size remains unchanged (210,3 µm² for control vs 229.2 µm² for Smo-CA and 213.8 µm² 
for Smo-DN; p = 0.26 and p = 0.48 between control and Smo -DN, Mann-Whitney test; Fig. 1D). 
In hippocampal neurons, exogenous treatment with Shh or Smo agonist (SAG) upregulate 
presynaptic nerve terminals (Mitchell et al., 2012). These observations led us to investigate whether 
Smo-CA or Smo-DN could modulate the density of presynaptic terminals in electroporated cortices. In 




order to assess the possible changes at the presynaptic levels, we performed quantitative analysis of the 
area fraction of synaptophysin on MAP2-positive neurons at P30. Compared with control GFP, Smo-
DN electroporated tissues showed a significant decrease in the area fraction of synaptophysin 
immunolabeling (16.05 % for Smo-DN vs 19.67 % for control; p = 0.01, Mann-Whitney test; Fig. 1E), 
whereas Smo-CA increased the area fraction of synaptophysin-positive synapses (24.77 % for Smo-CA; 
p  = 0.01 when compared to control and p < 0.0001 when compared to Smo-DN, Mann-Whitney test; 
Fig. 1E). 
Recent evidences indicate that Smo signaling pathway inhibits neuronal apoptosis (Wang et al., 
2018), whereas loss of Smo activity leads to increased neuronal apoptosis  (Qin et al., 2019). In order to 
assess if Smo-CA or Smo-DN induces apoptosis in electroporated neurons, we performed 
immunohistochemical analysis for cleaved caspase-3, a marker for cell apoptosis (Logue and Martin, 
2008) on electroporated rats at P15. Quantification of cleaved caspase-3-positive neurons shows no 
significant difference between the constitutively active mutant (0.24 ± 0.13 % and 0.34 ± 0.23 % in 
respectively Smo-CA and control; p = 0.70, Mann-Whitney test; Fig. 1F and G) or dominant negative 
(0.23 ± 0.15; p = 0.74, Mann-Whitney test; Fig. 1F and G) forms of Smo when compared to GFP control 
tissues.  
 Altogether, these observations indicate that expression of Smo-CA or Smo-DN does not alter the 
mean neuronal density and the positioning of pyramidal neurons in the cerebral cortex. Moreover, these 
results also suggest that IUE of Smo-related constructs does not affect apoptosis mechanisms in the 
postnatal cerebral cortex. By contrast, Smo-CA and Smo-DN change significantly the formation of 
synaptic terminals. These observations are in accordance with previous findings showing Smo-
dependent enhancement of synapse formation in hippocampal neurons (Mitchell et al., 2012).  
 
Smo-related constructs regulate the expression of its downstream target genes 
To investigate the functional expression of the two Smo-related constructs, we performed 
immunofluorescence labeling by using antibody raised against Smo protein in somatosensory cortical 
tissues overexpressing Smo-related constructs at P15. As illustrated in figure 2A, the anti-Smo antibody 
detected well the expression of Smo-CA and Smo-DN in the electroporated somatosensory cortex. Smo 




activation mobilizes activator forms of Gli transcription factors, which in turn lead to an increase of 
Ptch1 and Gli1 expression (Jacob and Lum, 2007). To validate functional expression of Smo-related 
constructs, we quantified Gli1 and Ptch1 mRNA in cortices overexpressing Smo-CA or Smo-DN 
mutants using qRT-PCR. As expected, Gli1 mRNA expression are increased in Smo-CA when 
compared with GFP control animals  (median values: 1.39 a.u. vs 0.76 a.u. in respectively Smo-CA and 
control; p = 0.041, Mann-Whitney test; Fig. 2B), and conversely decreased in Smo-DN (0.48 a.u.; p = 
0.039 when compared to control, Mann-Whitney test; Fig. 2B). When compared with control or Smo-
CA electroporated tissues, Ptch1 mRNA transcripts are downregulated in Smo-DN rats (3.61 a.u. in 
Smo-DN vs 6.97 a.u. in control and 6.21 a.u. in Smo-CA; p = 0.026 and p = 0.008 respectively, Mann-
Whitney test; Fig. 2C). No significant difference is observed for Ptch1 mRNA between control and 
Smo-CA (6.21 a.u. for Smo-CA; p = 0.66, Mann-Whitney test; Fig. 2C). We next measured Shh protein 
expression levels in the somatosensory cortex of GFP, Smo-CA and Smo-DN at P15 and P30 by ELISA. 
Our results indicate that Shh protein is expressed at a constant and similar level in all samples analyzed 
(P15: 2.58 ng/mL for control vs 2.42 ng/mL for Smo-CA and 1.93 ng/mL for Smo-DN; p > 0.05; P30: 
2.27 ng/mL for control vs 2.11 ng/mL for Smo-CA and 2.57 ng/mL for Smo-DN; p > 0.05, Mann-
Whitney test; Fig. 2D).  
 These results confirm that in electroporated somatosensory cortices, the constitutively active 
form of Smo significantly promotes the expression of the target gene Gli1 whereas the dominant 
negative Smo acts in the opposite way by reducing its expression. 
 
Smo controls the developmental GABA excitatory to inhibitory shift 
Cortical neuronal network construction during postnatal period requires the depolarizing to 
hyperpolarizing shift of GABA to occur at a precise timing during maturation (Ben-Ari and Holmes, 
2005; Wang and Kriegstein, 2009; Wu and Sun, 2015). Because Shh signaling plays a nodal role in 
brain development (Álvarez-Buylla and Ihrie, 2014; Yao et al., 2016)(Álvarez-Buylla and Ihrie, 2014; 
Yao et al., 2016; Delmotte et al., 2020), we investigated whether the manipulation of Smo activity will 
affect the onset of GABA excitatory/inhibitory postnatal shift at the network level. We performed field 
recordings of Multi Unit Activity (MUA) in acute cortical slices from control (GFP), Smo-CA and Smo-




DN rats and measured the effect of bath application of the GABAAR agonist isoguvacine (10 µM) on 
their spiking activity at P14, P20 and P30. Accordingly to the known depolarizing action of GABA in 
the immature neocortex (Kirmse et al., 2015; Riffault et al., 2018), isoguvacine induced an increase of 
spiking activity at P14 in cortical slices from control and Smo-DN rodents (median values: +33.87 %; 
p = 0.019 and +86.12 %; p = 0.019 respectively, Wilcoxon matched-pairs signed test; Fig. 3A and B). 
In contrast, isoguvacine decreased the spiking activity in Smo-CA mutants (-12 %; p = 0.009, Wilcoxon 
matched-pairs signed test, Fig. 3A and B). At P20 (Fig. 3B), isoguvacine induced either a decrease or 
an increase of spiking activity in control (-11.37 %; p = 0.519, Wilcoxon matched pairs signed test; Fig. 
3B). In slices obtained from Smo-CA rats we observed a decrease of spikes frequency (-47.03 %; p = 
0.011, Wilcoxon matched-pairs signed test) whereas in Smo-DN, isoguvacine still increased spikes 
frequency (+60.21%; p = 0.042, Wilcoxon matched-pairs signed test). At P30 (Fig. 3A-C), isoguvacine 
induced a decrease in spikes frequency from control and Smo-CA cortical slices (-22.86 % and -42.15 
%; p = 0.008 and p = 0.015 respectively, Wilcoxon matched-pairs signed test), whereas it increases the 
spiking activity in Smo-DN rats (+12.89 %; p = 0.037, Wilcoxon matched-pairs signed test).
 Thus, the overall effects of isoguvacine on the spiking activity in the electroporated cortical 
slices suggest that the constitutively active and the dominant negative forms of Smo accelerate and delay 
respectively the developmental hyperpolarizing GABA shift (p < 0.0001, Chi-square test; Fig. 3C). In 
developing neocortex, the depolarizing-hyperpolarizing shift of GABA depends primarily on 
enhancement of the functional expression of KCC2 (Ben-Ari et al., 1989; Rivera et al., 1999). To 
investigate whether the hyperpolarizing shift of GABA observed in Smo-CA rats might involve 
activation of KCC2 we applied the KCC2-selective blocker VU0463271 (VU) on somatosensory cortex 
slices obtained from Smo-CA rats at P14. VU application shifted the isoguvacine response from 
inhibitory to excitatory when compared with non-treated Smo-CA slices (-12 % vs +57.1% with VU; p 
= 0.0009, Mann-Whitney test; Fig. 3D).  
 Collectively, our data suggest that increasing Smo activity prematurely shifts GABA polarity 
from excitatory to inhibitory in a KCC2-dependent manner, whereas inhibiting Smo signaling delays 
the switch in GABA polarity. 
 




Smo signaling controls chloride homeostasis 
To further link Smo signaling with the shift in GABA polarity and neuronal chloride homeostasis, we 
performed gramicidin-perforated patch-clamp technique to measure the GABAA reversal potential 
(EGABA) on dissociated hippocampal cultures in immature neurons (9 DIV). Consistent with our results 
obtained in cortical slices, the measurements of EGABA in Smo-CA transfected neurons showed more 
hyperpolarized values when compared to control mCherry (-61.63 mV in Smo-CA vs -50.13 mV in 
control p = 0.008, Mann-Whitney test; Fig. 4A and B). Contrary to action of Smo-CA, the 
overexpression of Smo-DN did not produce statistically significant change of EGABA as compared to 
control mCherry transfected neurons (–57.13 mV in Smo-DN; p = 0.38, Mann-Whitney test; Fig 4B). 
To corroborate the results obtained in neuronal cultures we studied whether Smo signaling 
modifies [Cl-]i in acute slices of somatosensory cortex isolated from Smo-CA and Smo-DN rats. For 
this purpose, mCherry control, Smo-CA or Smo-DN were co-electroporated in utero at E15 with 
constructs encoding ratiometric Cl-sensor (Friedel et al., 2013, 2015) (Fig. 4C). Electroporated slices 
prepared at postnatal days P10 and P30 harbored hundreds of neurons expressing Cl--Sensor in cortical 
layers V/VI. The bath application of isoguvacine (10 µM, 3 min) to P10 Smo-DN and control slices 
produces a uniform decrease of R430/500 (indicated by an arrowhead in Fig. 4D and by the negative value 
of ΔR/R in Fig. 4F), reflecting a chloride ion extrusion characteristic of depolarizing action of GABA 
(median values: -0.04 a.u. for Smo-DN vs -0.09 a.u. for control; p = 0.17, Mann Whitney test; Fig. 4B 
and D), whereas in Smo-CA slices, isoguvacine triggered either an increase, no change or slight decrease 
of R430/500. The median of these changes in Smo-CA slices was +0.00 a.u. and statistical analysis revealed 
significant difference when compared to control (p = 0.005, Mann Whitney test; Fig. 4D and F). This 
difference indicates that in Smo-CA slices GABA is switching from depolarizing to hyperpolarizing 
actions. In P30 control and Smo-CA slices, isoguvacine produced a chloride influx (indicated by an 
arrow in Fig. 4E) as shown by the positive value of ΔR/R (+0.22 a.u. for control vs +0.26 a.u. for Smo-
CA; p = 0.63, Mann-Whitney test; Fig. 4E and F), whereas Smo-DN slices showed a slight increase of 
R430/500 (+0.06 a.u.; p = 0.002 and p = 0.01 when compared to control and Smo-CA respectively; Fig. 
4E and F). The latter finding suggest that Smo-dependent pathway is active at rest in mature P30 neurons 
to maintain the low [Cl-]I and hyperpolarizing inhibitory action of GABA. The inhibition of Smo action 




using Smo-DN leads toincrease [Cl-]I that reduces inhibitory strength of GABA. Thus, in both immature 
acute slices and primary cultures, activation of Shh using Smo-CA lead to hyperpolarizing shift of Cl-, 
whereas Smo-DN did not affect the [Cl-]I at this stage. 
 
Smo regulates the activity of KCC2 
The formation of KCC2-dependent developmental shift of GABA rely on complex mechanism 
involving progressive increase of the amount of KCC2 protein and its posttranslational modifications 
via at least two distinct phosphorylation sites, serine 940 (Ser940) and threonine 1007 (Thr1007) (Medina 
et al., 2014; Moore et al., 2017; Côme et al., 2019a). We measured the protein and mRNA expression 
of KCC2 from the somatosensory cortices of Smo-CA and Smo-DN rats at P10. We have observed 
similar levels between control and Smo-related constructs for KCC2 mRNA (median values: 5.02 a.u. 
for control tissues vs 3.3 a.u. for Smo-CA, p = 0.84; and 2.92 a.u. for Smo-DN, p = 0.42 compared to 
control; Mann-Whitney test; Fig. 5A) and proteins (1.23 a.u. for control tissues when normalized to ß3 
tubulin vs 1.26 a.u. for Smo-CA and 1.25 a.u. for Smo-DN; p = 0.48 and p = 0.48 respectively, Mann 
Whitney test; Fig. 4B and C). The membrane stability and transporter activity of KCC2 are dependent 
on the phosphorylation state of intracellular C-terminus domains. For instance, phosphorylation of the 
Ser940 residue increases stability and functionality of KCC2, whereas phosphorylation on the Thr1007 
residue enhances KCC2 endocytosis (Lee et al., 2007; Medina et al., 2014). To determine which steps 
in KCC2 trafficking may be regulated by Smo-related constructs, we carried out quantitative 
immunoblotting assay using antibodies recognizing phosphorylated forms of Ser940 (Lee et al., 2011) 
and Thr1007 (de Los Heros et al., 2014).  We found that the ratio of phospho-Ser940 (pKCC2 S940) to total 
KCC2 protein (pKCC2 S940/KCC2) is upregulated in Smo-CA electroporated cortices when compared 
to control and Smo-DN conditions (0.56 a.u. for Smo-CA vs 0.39 a.u. for control and 0.27 a.u. for Smo-
DN; p = 0.02 and p = 0.02 respectively compared to Smo-CA, Mann-Whitney test; Fig. 5B and D). The 
ratio of pKCC2 Thr1007 to total KCC2 protein (pKCC2T1007/KCC2) was not modified in Smo-related 
constructs (0.90 a.u. for control tissues vs 0.89 a.u. for Smo-CA and 0.78 a.u. for Smo-DN; p = 0.88 and 
p = 0.17, when compared to control respectively, Mann-Whitney test; Fig. 5B and E).  
 Together, these data suggest that enhanced Smo activity led to KCC2 post-translational 




modifications, with increased Ser940 phosphorylation in Smo-CA electroporated somatosensory cortex. 
 
The dominant-negative form of Smo affects the stability of KCC2pHext to the plasmalemmal 
surface by promoting endocytosis  
The phosphorylation of Ser940 described above is well known for its ability to stabilize KCC2 in the 
plasma membrane whereas dephosphorylation of Ser940 promotes KCC2 endocytosis (Lee et al., 2007; 
Kahle et al., 2013). We therefore assessed whether Smo-related constructs are able to regulate KCC2 
trafficking to the cell surface. As tool we used a KCC2 construct tagged in an external loop with a 
fluorescent protein pHluorin (KCC2-pHext) (Kahle et al., 2014). This construct allows both measurement 
of KCC2-pHext -dependent shift of [Cl
-]i and visualization of surface expression/internalization of 
KCC2-pHext. (Friedel et al., 2015, 2017). 
As expected, the overexpression of KCC2-pHext in 9 DIV neurons resulted in a negative shift of 
EGABA (median values from -50.13 mV to -86.25 mV; p < 0.0001, Mann-Whitney test; Fig. 6A and B), 
indicating also that at least some portion of KCC2-pHext molecules were delivered to the plasma 
membrane. The overexpression of Smo-CA did not produce additional hyperpolarizing shift of EGABA, 
in KCC2-pHext -positive neurons (-83.82 mV for Smo-CA + KCC2-pHext vs -86.25 mV for mCherry + 
KCC2-pHext; p = 0.69, Mann-Whitney test; Fig. 6A and B) whereas overexpression of Smo-DN resulted 
in a significant depolarizing shift of this parameter (-53.1 mV in Smo-DN + KCC2-pHext vs -86.25 mV 
in mCherry+ KCC2-pHext; p = 0.006, Mann-Whitney test; Fig. 6A and B) indicating on either Smo-DN-
dependent inactivation of the membrane pools of KCC2-pHext or reduction of its expression in plasma 
membrane.  
To further corroborate this study, we performed a live-staining analysis of surface 
expressed/internalized KCC2-pHext. Three different pools of KCC2-pHext were revealed using multistep 
immunolabeling protocol: the total expressed amount of protein (Ft), the amount of KCC2-pHext cell 
surface expression (Fm) and the amount of KCC2-pHext internalized (Fi) (Fig. 6C). As positive and 
negative controls we used overexpression of KCC2-pHext mutants T906A/T1007A (A/A-KCC2-pHext) 
and ΔNTD-KCC2-pHext known for their increased and perturbed surface expression abilities, 
respectively (Friedel et al., 2017). In the performed experiments, the live-cell immunolabelling of the 




control non-mutated KCC2-pHext revealed well detectable Fm signal in form of clusters, whereas the 
post-hoc multistep immunolabelings revealed Fi pool of molecules and total amount of expressed 
KCC2-pHext (Fig.6C). The relative amounts of Fm and membrane labeled cluster size in KCC2-pHext 
neurons were lower than those in A/A-KCC2-pHext expressing neurons and significantly higher that the 
values revealed in ΔNTD-KCC2-pHext – transfected cells (median values: For Fm: 0.94 a.u. for KCC2-
pHext vs 1.49 a.u. for A/A-KCC2-pHext and 0.008 a.u. for ΔNTD-KCC2-pHext; p = 0.002 and p < 0.0001, 
respectively, Fig. 6E; For single cluster membrane size: 1.02 a.u. for KCC2-pHext vs 1.09 a.u. for A/A-
KCC2-pHext and 0.55 a.u for ΔNTD-KCC2-pHext; p < 0.0001 and p < 0.0001, respectively; Mann-
Whitney test; Fig. 6G). The co-expression with KCC2-pHext of Smo-CA did not produce statistically 
significant change in Fi, Fm or single surface labeled cluster size (Fig. 6E, F and G). By contrast, neurons 
co-expressing KCC2-pHext and Smo-DN showed a significant twofold higher internalization rate of 
labeled KCC2-pHext molecules (0.84 a.u. for KCC2-pHext vs 2.51 a.u. for Smo-DN + KCC2-pHext; p < 
0.0001; Fig. 6C and F), significant twofold lower amount of Fm (0.94 a.u. for KCC2-pHext vs 0.57 a.u. 
for Smo-DN + KCC2-pHext; p = 0.009; Mann-Whitney test; Fig. 6C and E) and significantly smaller 
size of surface located KCC2-pHext clusters (1.02 a.u. for KCC2-pHext vs 0.92 a.u. for Smo-DN + KCC2-
pHext; p < 0.0001, Mann-Whitney test; Fig. 6G).  
Thus, consistent with data illustrated in Figures 3-6, both [Cl-]i measurement and live-cell 
immunolabelling revealed a striking Smo-dependent change in functioning and surface expression of 
KCC2-pHext. 
 
Smo-DN rats display increased susceptibility to PTZ-induced seizures 
Large number of studies have illustrated that the KCC2 dysfunction facilitates initiation of epileptic 
seizures (Chen et al., 2017; Moore et al., 2018). The changes of KCC2’s Ser940 phosphorylation that 
modify neuronal chloride homeostasis and depolarizing strength of GABA strongly affect the seizures 
susceptibilities in KCC2 transgenic mice (Silayeva et al., 2015). We finally investigated whether 
overexpression of Smo mutants may influence the susceptibility to seizures. Smo-DN, Smo-CA and 
age-matched control rats (transfected with GFP alone) at P30 were intraperitoneally injected with 
subconvulsive doses of PTZ (25 mg/kg; Fig. 7A), an inhibitor of the GABAA receptors (Klioueva et al., 




2001). Previous studies showed that the lowest threshold susceptibility to PTZ can be observed during 
the first 2 postnatal weeks and the highest at around P30 (Vernadakis and Woodbury, 1969; Klioueva 
et al., 2001). These results suggest that the vulnerability to PTZ is correlated to the maturation of 
GABAergic system during postnatal development. Injections of PTZ were continued every 10 min until 
each rat had generated generalized tonic-clonic seizure. Seizure susceptibility and severity were 
quantified with the canonical Racine’s scale of seizure severity (Lüttjohann et al., 2009), including dose 
and latency to onset of the first generalized tonic-clonic seizure. Generalized seizures in Smo-DN rats 
occur at lower doses of PTZ (median values: 87.5 mg/kg compared with 100 mg/kg for both control and 
Smo-CA rats; p = 0.005 and p = 0.003 respectively, Mann-Whitney test; Fig. 7C) and with shorter 
latencies than control and Smo-CA rats (30.83 min compared with 32.71 min in control and 32.69 min 
in Smo-CA; p = 0.041 and p = 0.024 respectively; Mann-Whitney test; Fig. 7B). No significant 
difference is observed between control and Smo-CA rats in the latency (32.69 min compared with 32.71 
min in control; p = 0.5158; Fig. 7B) or cumulative dose of PTZ to induce tonic-clonic seizures (p = 
0.501; Fig. 7C).  
 These results indicate that reduced-seizure threshold in Smo-DN rats could be due to a 




In the present study, we investigated the actions of Shh-Smo signaling pathway on GABAergic 
transmission in vivo and ex vivo in the rat somatosensory cortex and in vitro in primary culture of 
hippocampal neurons using dominant-negative (Smo-DN) and constitutively active (Smo-CA) forms of 
Smo. We show that activation of Smo signaling in immature neurons at early postnatal stages 
accelerated the process of GABAergic switch form depolarizing to hyperpolarizing activity in a KCC2-
dependent manner, leading to a low intracellular chloride concentration. Conversely, Smo signaling 
blockade altered the phosphorylated state of KCC2 and membrane stability, weakening the GABAergic 
inhibition on later stages of the development, and resulting in an increase of seizure susceptibility. These 
findings reveal an unexpected function of the G-protein-coupled receptor Smoothened on chloride 




homeostasis regulation and, in particular, on the timing of the GABA shift from depolarizing- to 
hyperpolarizing in the postnatal developing brain.  
 The postnatal developmental switch in GABA polarity is tightly regulated by the actions of 
several peptides including neurotrophic factors (Kelsch et al., 2001; Aguado et al., 2003; Ludwig et al., 
2011; Riffault et al., 2018), hypothalamic neurohormones (Tyzio et al., 2006; Leonzino et al., 2016; 
Spoljaric et al., 2017), central and peripheral hormones (Sawano et al., 2013; Dumon et al., 2018). 
Hence, the precise timing of GABAergic polarity shift depends on the balance between factors 
promoting or delaying the onset of GABAergic inhibitory transmission. It is noteworthy that these 
factors are developmentally regulated and/or operate within specific time windows to control the 
functional expression of KCC2 and associated chloride homeostasis and, consequently the postnatal 
maturation of GABAergic transmission in the central nervous system. Interestingly, the excitatory action 
of GABA at early stages of the development coincide with the predominance of trophic factors 
responsible for the inhibition of KCC2 expression and function, such the immature form of BDNF 
(proBDNF) (Riffault et al., 2018) and the adipocyte hormone leptin (Dumon et al., 2018). These two 
factors are expressed shortly after birth and surge during the first postnatal week in rodents (Menshanov 
et al., 2015; Dumon et al., 2018). They have been shown to promote a low KCC2 protein and mRNA 
expression levels and consequently a high intracellular chloride concentration, thus maintaining a 
depolarizing action of GABA in neonates. The developmental decreases of leptin and proBDNF 
observed at the end of the first postnatal week in rodents, are concomitant to an increase in oxytocin 
(Tyzio et al., 2006; Leonzino et al., 2016), mature BDNF (mBDNF) (Maisonpierre et al., 1990) and 
thyroid hormones (Sawano et al., 2013), which in turn, up-regulate KCC2, leading to a low intracellular 
chloride and a hyperpolarizing action of GABA. Although we did not observe any difference in the level 
of Shh proteins between P15 and P30, a study demonstrated that Shh expression paralleled the temporal 
expression of mBDNF in the cortex of rodents with a nearly undetectable level at birth and a continuous 
increased expression at both mRNA and protein levels from during the two first postnatal weeks (Rivell 
et al., 2019). This temporal expression of Shh and its signaling partners during postnatal brain 
development has been shown to play a role in neuronal network construction through axonal growth and 
synaptic maturation (Yao et al., 2015). Here, we uncover a new critical function of Shh components in 




the regulation of the GABA polarity switch. Indeed, we showed that activation of the GABAA receptor 
by isoguvacine, in immature (i.e. post-natal day 14) Smo-CA cortical neurons results in an influx of 
chloride and a decrease in spiking activity whereas, in mature (i.e. post-natal day 30) dominant negative 
Smo cortical neurons (Smo-DN), maintains a depolarizing and excitatory action of GABA. Thus, in the 
absence of Smo signaling, the GABA shift is delayed, thereby leading to an altered chloride homeostasis 
and higher susceptibility to seizures, presumably reflecting an unbalanced excitation to inhibition (E/I) 
ratio. E/I imbalance has been linked to cognitive disorders such as schizophrenia, autism spectrum 
disorders (ASD), depression and epilepsy (Brambilla et al., 2003; Ben-Ari and Holmes, 2005; Kuzirian 
and Paradis, 2011; Mueller et al., 2015). Abnormal levels of Shh have been also observed in ASD 
patients with either an increased serum level in children or a decreased mRNA level in post-mortem 
adult human brain tissue from autism patients (Choi et al., 2014; Halepoto et al., 2015). In addition, 
mutations in Ptchd1, a gene displaying secondary structures similar to Ptch1, are found in patients with 
intellectual disability and ASD (Ung et al., 2018). Consistent with a possible role of Shh components in 
the regulation of the E/I balance, these observations also suggest that an alteration in Shh-Ptch-Smo 
pathway may have an implication to the pathophysiological mechanisms in ASD. In line with these 
observations, the role of Shh signaling in neuronal activity has been recently addressed in an elegant 
study (Hill et al., 2019) showing that the selective disruption of Shh signaling with a conditional 
knockout of Smo leads to an increase in neuronal excitability of cortical neurons, thus highlighting the 
importance of Shh on the E/I equilibrium and the construction of functional cortical networks. The 
results from this study are consistent with our findings showing that Shh-Smo signaling blockade 
increases neuronal network excitability in rodents expressing the dominant negative form of Smo. 
Furthermore, we found that blockade of Smo activity in Smo-DN rodents leads to a decrease in KCC2 
expression and to a reduced threshold for PTZ-induced tonic-clonic seizure. In agreement with a 
previous study by Chen et al. (Chen et al., 2017), these results suggest that downregulation of KCC2 
function may contribute to epileptic seizures. The implication of Shh signaling in epilepsy and seizures 
has been indirectly addressed in previous studies showing that somatic mutations in Shh pathway genes 
in human are associated with hypothalamic hamartoma and drug-resistant epilepsy (Hildebrand et al., 
2016; Saitsu et al., 2016). Likewise, the Shh expression was increased in hippocampus and neocortex 




from both human and animal models of temporal lobe epilepsy (TLE) (Fang et al., 2011), thus 
suggesting a potential relationship between epilepsy and Shh activity. In line of the above studies, Feng 
et al. (Feng et al., 2016) reported that during TLE development, Shh contributes to epileptogenesis 
through the inhibition of glutamate transporters function leading to abnormal extracellular glutamate 
levels, whereas the blockade of Shh signaling pathway reduced the severity of seizures. Together, these 
observations can lead to opposing interpretations regarding the possible interplay between Shh pathway 
and epilepsy. These apparent discrepancies could be explained by the treatments utilized (i.e. acute 
seizure models with PTZ versus spontaneous seizures in the pilocarpine model of chronic TLE) that are 
able to activate different downstream signaling cascades (Choudhry et al., 2014). Moreover, other 
studies have found that the Shh-Smo/Gli pathway activation increased the synthesis and secretion of 
neurotrophic factors like nerve growth factor (NGF) and BDNF (Radzikinas et al., 2011; Bond et al., 
2013; Chen et al., 2018), which they may have neuroprotective effects in TLE (Paradiso et al., 2009; 
Bovolenta et al., 2010; Falcicchia et al., 2018). Clearly, additional studies are needed to get a deeper 
knowledge on the cellular and molecular mechanisms linking epilepsy to Shh pathway components.  
Importantly, our in vitro experiments revealed that in immature neurons of both primary rat 
hippocampal cultures and rat neocortical acute slices the EGABA shifted towards a more hyperpolarized 
level in Smo-CA expressing neurons and indicating that Smo-CA initiated decrease of neuronal [Cl-]i. 
In immature neurons the increased [Cl-]i and correspondent depolarizing values of EGABA are determined 
primarily by effective intrusion of Cl- by sodium/potassium/chloride cotransporter type 1 (NKCC1) and 
absence of the effective Cl- extrusion by KCC2. The blockage of NKCC1 (Yamada et al., 2004) or 
activation of KCC2 (Khirug et al., 2005; Inoue et al., 2012; Dumon et al., 2018) lead both to 
hyperpolarizing shift of EGABA. The present study revealed a novel Smo-dependent pathway of KCC2-
upregulation during neuronal development. Whether Smo pathway regulates also NKCC1 activity as 
well as other transporters and channels controlling Cl- homeostasis in immature neurons should be a 
subject of independent respective projects.  
The Cl- extrusion activity of KCC2 in developing neurons depends on the amount of protein 
expression (Rivera et al., 1999) and its post-translational modifications that regulate the KCC2’s surface 
targeting and clustering (Medina et al., 2014; Côme et al., 2019b). Thus, KCC2 cycle between synaptic 




sites and endocytic compartments which depends on the phosphorylation and/or dephosphorylation state 
of different amino-acid residues (Kahle et al., 2014; Kahle and Delpire, 2016; Côme et al., 2019b), but 
also this membrane turnover requires regulation to its cytosolic N- and C-termini (Friedel et al., 2017). 
For instance, N-terminal truncation of KCC2 prevents its export at the cell surface, whereas C-terminal 
truncation leads to a decreased surface expression of KCC2 (Friedel et al., 2017). The observed loss of 
KCC2 surface expression in the C-terminal mutants is explained by an increase in the internalization 
rate without affecting cell surface delivery. Furthermore, KCC2 function can also be regulated through 
lateral diffusion at the plasma membrane (Chamma et al., 2013). This suggests that KCC2 membrane 
dispersion may, in turn, mediate membrane destabilization and endocytosis resulting in intracellular 
chloride homeostatic dysregulation (Côme et al., 2019b). In agreement with this, we found that 
inhibition of Smo signaling pathway in mature neurons induces a decrease in KCC2 cluster size and 
enhances the intracellular concentration of chloride that sets EGABA at more positive values than the 
resting potential with a reduced plasmalemmal levels of KCC2 cell surface expression levels. We further 
show that these effects occur through an increased rate of KCC2 turnover. 
 In conclusion, these data uncovered an unexpected role of Shh-Smo components during early 
postnatal development through the control of chloride homeostasis. Thus, Smo signaling will tune up or 
down GABA inhibitory transmission by controlling phosphorylation of KCC2 that affects its stability 
in the cell membrane and modulates neuronal chloride homeostasis. Finally, these results suggest that 
Smo signaling is able to set the cursor of GABAergic inhibitory switch during this critical maturational 
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Figure 1: Cortical expression pattern of Smo-related constructs. (A) Representative neocortical 
section showing laminar position of transfected cells electroporated at E15 with control GFP (control) 
or co-electroporated with Smo-CA (Smo-CA) or Smo-DN (Smo-DN) and processed postnatally at P15 
and co-immunostained with NeuN (blue) and FoxP2 (red). GFP fluorescence intensity profile shows 
that E15 generated neurons are distributed mainly in deeper layers V-VI. Scale bar = 250 µm. (B) Box 
plots of cortical thickness in GFP (control), Smo-CA and Smo-DN brains. Mann-Whitney test. (C) Box 
plots of neuronal density in GFP (control), Smo-CA and Smo-DN brains. (D) Box plots of neurons soma 
size on P15 electroporated rats. (E) Box plots of synaptophysin area fraction normalized with MAP2 
area fraction (left) and (right) example of immunofluorescence signal of P30 cortical section expressing 
Smo-DN + GFP, co-immunostained with Synaptophysin (red) and MAP2 (blue). Scale bar = 30 µm. 
(F) Immunofluorescence signal of P15 cortical sections electroporated at E15 with GFP (control) with 
or without Smo-related constructs and immunolabeled with cleaved caspase-3 antibody. Scale bar = 100 
µm. (G) Ratio of cleaved caspase-3-positive neurons (apoptotic) per surface area and expressed as a 
percentage of control (GFP). Overexpression of Smo-CA or Smo-DN does not increase the number of 
apoptotic neurons compared to control (GFP). Errors bars are mean ± SD.  
Number of slices and rats are indicated in parenthesis. *p < 0.05; **p < 0.01; ***p < 0.001.  
 
Figure 2: Smo-related constructs regulate the expression levels of PTCH1 and Gli1. (A) Cells 
overexpressing Smo related constructs (green) and immunostained with Smo antibody (red) showed a 
similar localization (overlay). Scale bar = 25 µm. (B, C) Box plots of relative expression of Gli1 and 
PTCH1 mRNA transcripts in GFP (control), Smo-CA and Smo-DN rats. (B) Box plots of Gli1 and (C) 
PTCH1 genes expression are normalized to GAPDH expression in the same RNA preparation. n = 6 
rats for each condition. (D) Shh is expressed in post-natal somatosensory cortex. Box plots show median 
Shh protein concentration measured by ELISA at P15 and P30 in GFP (control), Smo-CA and Smo-DN 
from rat somatosensory cortex tissue lysate. n = 4 rats for each condition. *p > 0.05; ** p < 0.01. 
 
Figure 3: The developmental shift in the polarity of GABAAR mediated responses is modulated in 




cortical neurons expressing the dominant negative or the constitutively active forms of Smo. (A) 
Effects of isoguvacine (10 µM) in cortical slices from control GFP, Smo-CA and Smo-DN rats: 
representative traces of spontaneous extracellular field potentials (left column) recorded in 
electroporated area of cortical slices at P14 in GFP (control) and Smo-CA and  at P30 in control and 
Smo-DN rats (left column). Corresponding time course of normalized frequency MUA is shown beside 
(right column) (B) Box plots of relative change of isoguvacine-dependent MUA frequency in 
electroporated rats at P14, P20 and P30. Numbers in parenthesis indicate the number of slices recorded 
and rats used. *p < 0.05; **p < 0.01 compared to control baseline; Wilcoxon test. (C) Developmental 
regulation of GABAergic excitation in electroporated rats. Proportion of excited slices is the proportion 
of slices showing an increase of 20% or more of MUA frequency during isoguvacine application. 3-5 
rats per age and condition. ***p < 0.001; Chi-square test. (D) Box plots of relative changes in MUA 
frequency during isoguvacine application with and without VU0463271 (VU) a KCC2-selective blocker 
application on Smo-CA rats at P14. n = 5 rats. *p < 0.05; Wilcoxon test. 
 
Figure 4: Smo signaling controls chloride homeostasis in cultured neurons and acute slices. (A) 
Gramicidin perforated patch clamp recordings of I-V relationships for isoguvacine currents in mCherry 
only (control) or mCherry plus Smo-CA or Smo-DN in rat hippocampal primary neuronal cultures (9 
DIV). Inserts depict the isoguvacine currents for control condition. Scale bar, 500 ms, 50 pA. (B) Box 
plots of EGABA in the indicated conditions. The number of cells recorded and cultures used are indicated 
in parenthesis. (C) Typical images of Cl-Sensor fluorescence excited at 500nm in slice from P30 rat 
electroporated with Cl- Sensor plus Smo-CA. Rats were electroporated in utero at embryonic day 15 
with Cl-Sensor plus mCherry (control) or Cl-Sensor plus Smo-CA (Smo-CA) or Cl-Sensor plus Smo-
DN (Smo-DN). The regions of interest were drawn around the soma of cells located in the focal plane. 
5 to 10 neurons were analyzed per image. Data represent results obtained from 4-5 rats per experimental 
condition and 1-2 slices were recorded per animal. (D and E) Example of typical ratiometric 
fluorescence (R430/500) recordings at P10 (D) and P30 (E) from control, Smo-CA and Smo-DN rats. 
Horizontal bars indicate the times of application of ACSF containing isoguvacine. Arrows and 
arrowheads indicate different types of responses between control, Smo-CA and Smo-DN neurons at P10 




and P30. Data represent results obtained from 4-5 rats per experimental condition and 1-2 slices were 
recorded per animal. (D) Box plots quantification of fluorescence change of ΔR/R, where R is the mean 
of 5 measurements before isoguvacine application and ΔR is the difference between absolute maximum 
of isoguvacine-induced response. Number of slices and rats are indicated in parenthesis. *p < 0.01, **p 




 phosphorylation is regulated by Smo signaling. (A) Box plots of relative 
expression of KCC2 mRNA normalized to GAPDH mRNA level in P10 rats electroporated with GFP 
alone (Control), GFP + Smo-CA (Smo-CA) or GFP + Smo-DN (Smo-DN). N = 5 rats for each condition. 
(B) Immunoblots for total KCC2 and phosphorylated forms of KCC2 Ser940 (KCC2 pS940) and KCC2 
Thy1007 (KCC2 pT1007) (pKCC2) in protein extracts from P10 electroporated somatosensory cortices. 
(C, D and E) Box plots of normalized total KCC2 (C); KCC2 pSer940 (D), KCC2 pThr1007 (E) relative 
protein level. n = 4 rats for each condition. *p < 0.05; Mann-Whitney U test. 
 
Figure 6: Dominant negative form of Smo affects the stability of KCC2 to the plasmalemmal 
surface. (A)  Gramicidin perforated patch clamp recordings I-V relationships for isoguvacine currents 
in KCC2-pHext alone or co-transfected with Smo-CA (green) or Smo-DN (red) in hippocampal primary 
culture at 9 DIV. Inserts depict the isoguvacine currents for control condition. Scale bar, 500 ms, 50 pA. 
(B) Box plots of EGABA in the indicated conditions. Left panel show neurons transfected without KCC2-
pHext from data shown in Fig. 4A and B. Right panel show neurons co-transfected with KCC2-pHext. 
The number of cells recorded, and cultures used are indicated in parenthesis. (C) Representative images 
illustrating total, membrane and internalized pools of KCC2 with external tag (KCC2-pHext) in vehicle 
(control), and Smo-related transfected constructs in hippocampal primary culture neurons. KCC2 
construction stable to membrane (A/A KCC2) was used as positive control for KCC2 membrane 
trafficking. Neurons expressing a KCC2 mutant construction known to not be addressed to membrane 
(ΔNTD-KCC2) were proceeded in parallel experiments to ensure that immunocytochemistry on living 
neurons does not permeabilized the membrane. Scale bar 20μm. (D) Box plots of total protein (Ft), (E) 
normalized membrane (Fm), (F) internalized pool (Fi) fluorescence and (G) single membrane cluster 




size in cultured neurons expressing the indicated constructs. The number of cells and cultures used 
indicated in parenthesis are identical for all box plots. The sample size is the same for all box plots. *p 
<0.05, **p < 0.01, ***p<0.005, ****p<0.001; Mann-Whitney U test. 
 
Figure 7: Modified susceptibility to pentylenetrazol-induced (PTZ) seizures in Smo mutant rats. 
(A) Experimental paradigm design. (B) Box plots of latency needed to induce generalized tonic-clonic 
seizures in 3 groups of electroporated rats: control (electroporated with GFP), Smo-CA and Smo-DN. 
(C) Bar graph of PTZ cumulative dose needed to induce generalized tonic-clonic seizures. Bars are 
medians with experimental points. Numbers in parenthesis indicate the number of rats used. *p < 0.05; 
**p < 0.01; Mann-Whitney U test.  
 
